p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Lee M. Nadler(Dana-Farber Cancer Institute), Isabelle Grass(Harvard University Press), Alla Berezovskaya(Ontario Institute for Cancer Research), Bruce R. Blazar(University of Minnesota Medical Center), Gordon J. Freeman(Dana-Farber Cancer Institute), Patricia A. Taylor(University of Minnesota)
Cited by 235
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k